kurt g pike

Oncol iMed AstraZeneca

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 78 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood–Brain Barrier: the Discovery of AZD1390

Kurt G. Pike,Thomas A. Hunt,Bernard Barlaam,David Benstead,Elaine Cadogan,Kan Chen,Calum R. Cook,Nicola Colclough, Chao Deng,Stephen T. Durant,Andrew Eatherton,Kristin Goldberg,Peter Johnstro''m,Libin Liu, Zhaoqun Liu,J. Willem M. Nissink, Chengling Pang,Martin Pass,Graeme R. Robb,Caroline Roberts,Magnus Schou,Oliver Steward,Andy Sykes,Yumei Yan,Baochang Zhai,Li Zheng

Journal of Medicinal Chemistry（2024）

Cited2Views0WOSBibtex

Supplementary Figure 4 from AZD2014, an Inhibitor of Mtorc1 and Mtorc2, is Highly Effective in ER+ Breast Cancer when Administered Using Intermittent or Continuous Schedules

Sylvie M. Guichard,Jon Curwen,Teeru Bihani,Celina M. D'Cruz,James W.T. Yates,Michael Grondine,Zoe Howard,Barry R. Davies,Graham Bigley,Teresa Klinowska,Kurt G. Pike,Martin Pass,Christine M. Chresta,Urszula M. Polanska,Robert McEwen,Oona Delpuech,Stephen Green,Sabina C. Cosulich

openalex（2023）

Cited0Views0Bibtex

Supplementary Information from Orally Bioavailable and Blood–Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice

Jeremy Karlin,Jasmine Allen,Syed F. Ahmad,Gareth Hughes,Victoria Sheridan,Rajesh Odedra,Paul Farrington,Elaine B. Cadogan,Lucy C. Riches,Antonio Garcia-Trinidad,Andrew G. Thomason,Bhavika Patel, Jennifer Vincent,Alan Lau,Kurt G. Pike,Thomas A. Hunt,Amrita Sule,Nicholas C.K. Valerie,Laura Biddlestone-Thorpe,Jenna Kahn,Jason M. Beckta,Nitai Mukhopadhyay,Bernard Barlaam,Sebastien L. Degorce,Jason Kettle,Nicola Colclough,Joanne Wilson,Aaron Smith,Ian P. Barrett,Li Zheng,Tianwei Zhang, Yingchun Wang,Kan Chen,Martin Pass,Stephen T. Durant,Kristoffer Valerie

crossref（2023）

Cited0Views0Bibtex

Supplementary Tables 1 Through 4 from AZD2014, an Inhibitor of Mtorc1 and Mtorc2, is Highly Effective in ER+ Breast Cancer when Administered Using Intermittent or Continuous Schedules

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 3 from AZD2014, an Inhibitor of Mtorc1 and Mtorc2, is Highly Effective in ER+ Breast Cancer when Administered Using Intermittent or Continuous Schedules

openalex（2023）

Cited0Views0Bibtex

Supplemenary Figure 2 from AZD2014, an Inhibitor of Mtorc1 and Mtorc2, is Highly Effective in ER+ Breast Cancer when Administered Using Intermittent or Continuous Schedules

openalex（2023）

Cited0Views0Bibtex

Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRASG12C with Demonstrable CNS Penetration

Jason G. Kettle,Sharan K. Bagal,Derek Barratt,Michael S. Bodnarchuk,Scott Boyd,Erin Braybrooke,Jason Breed,Doyle J. Cassar,Sabina Cosulich,Michael Davies,Nichola L. Davies, Chao Deng,Andrew Eatherton,Laura Evans,Lyman J. Feron,Shaun Fillery,Emma S. Gleave,Frederick W. Goldberg,Miguel A. Cortes Gonzalez,Carine Guerot,Afreen Haider,Stephanie Harlfinger,Rachel Howells,Anne Jackson,Peter Johnstrom,Paul D. Kemmitt,Alex Koers,Mikhail Kondrashov,Gillian M. Lamont,Scott Lamont,Hilary J. Lewis,Libin Liu,Megan Mylrea, Samuel Nash,Michael J. Niedbala,Alison Peter,Christopher Phillips,Kurt Pike,Piotr Raubo,Graeme R. Robb,Sarah Ross,Matthew G. Sanders,Magnus Schou,Iain Simpson,Oliver Steward

JOURNAL OF MEDICINAL CHEMISTRY（2023）

Cited8Views0WOSBibtex

Supplementary Figure 1 from AZD2014, an Inhibitor of Mtorc1 and Mtorc2, is Highly Effective in ER+ Breast Cancer when Administered Using Intermittent or Continuous Schedules

openalex（2023）

Cited0Views0Bibtex

Supplementary Methods from AZD2014, an Inhibitor of Mtorc1 and Mtorc2, is Highly Effective in ER+ Breast Cancer when Administered Using Intermittent or Continuous Schedules

openalex（2023）

Cited0Views0Bibtex

Video 2 - ATMi Increases the Rate of Mitotic Catastrophe in Glioma Cells when P53 is Knocked Down. from Orally Bioavailable and Blood–Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice

Jeremy Karlin,Jasmine Allen,Syed F. Ahmad,Gareth Hughes,Victoria Sheridan,Rajesh Odedra,Paul Farrington,Elaine B. Cadogan,Lucy C. Riches,Antonio Garcia-Trinidad,Andrew G. Thomason,Bhavika Patel, Jennifer Vincent,Alan Lau,Kurt G. Pike,Thomas A. Hunt,Amrita Sule,Nicholas C.K. Valerie,Laura Biddlestone-Thorpe,Jenna Kahn,Jason M. Beckta,Nitai Mukhopadhyay,Bernard Barlaam,Sebastien L. Degorce,Jason Kettle,Nicola Colclough,Joanne Wilson,Aaron Smith,Ian P. Barrett,Li Zheng,Tianwei Zhang,Yingchun Wang,Kan Chen,Martin Pass,Stephen T. Durant,Kristoffer Valerie

openalex（2023）

Cited0Views0Bibtex

Author Statistics

#Papers: 78

#Citation: 2156

H-Index: 25

G-Index: 45

Sociability: 6

Diversity: 2

Activity: 8

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn